학술논문
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
Document Type
Article
Author
Source
In: The Lancet Neurology . (The Lancet Neurology, November 2021, 20(11):917-929)
Subject
Language
English
ISSN
14744465
14744422
14744422